News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
David Jackman addresses common lung cancer risk factors – Dana-Farber Cancer Institute
philips.com
Nov 26, 2024, 13:22

David Jackman addresses common lung cancer risk factors – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn:

“Smokers have a 20-fold increase in the risk of lung cancer compared to non-smokers.

David Jackman, MD, senior physician at Dana-Farber Cancer Institute, addresses common lung cancer risk factors like secondhand smoke, asbestos, radioactive substances, and others.”

Proceed to the video attached to the post.

More posts featuring Dana-Farber Cancer Institute.

cancer cigarette smoking Dana-Farber Cancer Institute David Jackman Lung cancer OncoDaily Oncology
Special Coverage
Blog
Apr 2, 2025, 14:29
Sotirios Bisdas: The integration of AI in medical imaging and oncology is transforming healthcare
Blog
Apr 2, 2025, 14:24
Webinar on the ARIA Guide for childhood cancer treatment - The Dorcas Cancer Foundation
Societies
Apr 2, 2025, 14:12
Fellows of ASCO (FASCO) Recipients For Last Quarter
Blog
Apr 2, 2025, 14:05
Isabel Mestres: Incredible work in cancer care in India
Blog
Apr 2, 2025, 13:48
David Planchard: Lung preceptorship leading by Fabrice Barlesi at Gustave Roussy
Blog
Apr 2, 2025, 13:40
Runcie C.W. Chidebe: Creating prostate cancer awareness and urging the government to fund research
Blog
Apr 2, 2025, 13:28
Gratitude for NIH Leaders: Honoring their Dedication and Impact
Blog
Apr 2, 2025, 13:20
Michael Sapienza: National Colorectal Cancer Awareness Month was full of activities
Drugs
Apr 2, 2025, 13:07
Patrick Hwu: Can neoantigen-specific TILs improve immunotherapy for gastrointestinal cancers?
Blog
Apr 2, 2025, 13:00
Annals of Research in Oncology - The new issue is now available
Blog
Apr 2, 2025, 12:56
Ajay Aggarwal: How NATCAN differs from other international audit programs and its future areas for development
Blog
Apr 2, 2025, 12:47
Akhil Santhosh: Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer